Anti-Kickback Statute

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 17, 2022
Health, Stark Law, Defendant, HBO, Warner Bros., U.S. Department of Defense Strategy for Operating in Cyberspace, AT&T, Justice, ADS, Remuneration, Genetics, Patient, Complaint, Prospectus, Register, Battle of Saint-Fulgent, Anti-Kickback Statute, COVID-19, U.S. Department of Justice Office of Legislative Affairs, Mergers and acquisitions, Physician, Annual report, Warner, BCS, Reward, AT, News, NYSE, Genetic testing, HBO Max, YSG, Disclosure, Turnaround ADR, ADR, Section 11 of the Canadian Charter of Rights and Freedoms, IPO, Federal, Medicare, Sale, Investment, Pharmaceutical industry, Music, Audit, Security (finance), P.C, Discovery, Barclays, WarnerMedia

Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

Key Points: 
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the Warner Bros. class action go to: https://bespc.com/cases/WBD
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Wednesday, November 16, 2022
Exchange, U.S. Department of Justice Office of Legislative Affairs, Stark, Stark Law, GPM, Genetics, Defendant, Court, Privacy Office of the U.S. Department of Homeland Security, News, Anti-Kickback Statute, Justice, Suite, Investment, Remuneration, Pharmaceutical industry, Battle of Saint-Fulgent

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, November 15, 2022
Law, Stark Law, Genetics, IPO, Defendant, Battle of Saint-Fulgent, Anti-Kickback Statute, Suite, Investment, Remuneration, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, November 14, 2022
Law, Investment, Stark Law, Class, Anti-Kickback Statute, Telephone, Remuneration, IPO, Defendant, Suite, Battle of Saint-Fulgent, People's Law Office, Barclays, Security (finance)

BENSALEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Fulgent Genetics, Inc. Securities Fraud Class Action Lawsuit

Retrieved on: 
Sunday, November 13, 2022
Stark Law, Central District, Anti-Kickback Statute, District court, Stark, Remuneration, News, Lead, U.S. Department of Justice Office of Legislative Affairs, Health, Insurance, Medicare, Physician, Justice, Disclosure, LLP, COVID-19, Fraud, Reward, Genetics, COPY, Battle of Saint-Fulgent, Genetic testing, Patient, Office of Inspector General, U.S. Department of Health and Human Services, Private investigator, Pharmaceutical industry, Architecture

Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Friday, November 18, 2022
Class Action Lawsuit, Professional Services, Legal, Law, Stark Law, Anti-Kickback Statute, Stark, Remuneration, Exchange, News, U.S. Department of Justice Office of Legislative Affairs, Court, Justice, Suite, Defendant, Genetics, Battle of Saint-Fulgent, Privacy Office of the U.S. Department of Homeland Security

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) securities between March 22, 2019 and August 4, 2022, inclusive (the Class Period).

Key Points: 
  • The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) securities between March 22, 2019 and August 4, 2022, inclusive (the Class Period).
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate

Retrieved on: 
Tuesday, November 15, 2022
Class Action Lawsuit, Professional Services, Legal, Stark Law, Court, Complaint, Person, Genetics, Anti-Kickback Statute, Remuneration, Private investigator, Battle of Saint-Fulgent

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/flgt .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/flgt .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 12, 2022
Disclosure, Federal, Sale, Reward, Complaint, EPS, BCS, Mission statement, ADS, Company, Anti-Kickback Statute, Investment, NASDAQ, Battle of Saint-Fulgent, Annual report, U.S. Department of Defense Strategy for Operating in Cyberspace, IPO, Q2, Federation, GLOBE, Health, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Medicare, War, Patient, SEC, U.S. Securities and Exchange Commission, Prospectus, Government, ADR Institute of Alberta, YSG, News, Remuneration, PLTR, COVID-19, Intelligence, Growth, NYSE, Justice, ADR, Physician, Genetic testing, Security (finance), Animal, Pharmaceutical industry, Audit, Palantir Technologies, Barclays, P.C

The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.

Key Points: 
  • The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.
  • On May 9, 2022, Palantir issued a press release announcing its Q1 financial results and guidance for Q2.
  • For more information on the Barclays class action go to: https://bespc.com/cases/BCS
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.

Retrieved on: 
Friday, November 11, 2022
Class Action Lawsuit, Professional Services, Legal, Disclosure, Reward, Stark, Battle of Saint-Fulgent, NASDAQ, Anti-Kickback Statute, Lead, Genetics, Office of Inspector General, U.S. Department of Health and Human Services, Health, U.S. Department of Justice Office of Legislative Affairs, Stark Law, COPY, Medicare, Patient, LLP, SEC, Fraud, News, Remuneration, COVID-19, Insurance, Justice, Physician, Genetic testing, Private investigator, Pharmaceutical industry

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent) ( NASDAQ: FLGT ).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent) ( NASDAQ: FLGT ).
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

ROSEN, A TOP RANKED LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action – FLGT

Retrieved on: 
Friday, November 11, 2022
Titan, Federal, Reward, Battle of Saint-Fulgent, NASDAQ, Genetics, Advertising, GLOBE, Health, Class, Anti-Kickback Statute, Medicare, I-Space (Chinese company), Stark Law, Court, Remuneration, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.